eudragit-e has been researched along with enalapril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TF; Cheng, WT; Lin, SY; Wang, SL | 1 |
| Abbadi, I; Alhnan, MA; Aziz, D; Isreb, A; Isreb, M; Sadia, M; Selo, A; Timmins, P | 1 |
2 other study(ies) available for eudragit-e and enalapril
| Article | Year |
|---|---|
Eudragit E accelerated the diketopiperazine formation of enalapril maleate determined by thermal FTIR microspectroscopic technique.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Diketopiperazines; Enalapril; Excipients; Kinetics; Maleates; Methacrylates; Methylmethacrylates; Piperazines; Spectroscopy, Fourier Transform Infrared | 2004 |
From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
Topics: Administration, Oral; Antihypertensive Agents; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Enalapril; Hydrochlorothiazide; Kinetics; Polymethacrylic Acids; Printing, Three-Dimensional; Solubility; Tablets; Technology, Pharmaceutical | 2018 |